tiprankstipranks

Metin Kurtoglu Insider Profile

4 Followers
Metin Kurtoglu, CTO at Cartesian Therapeutics, holds 51.03K shares in Cartesian Therapeutics (Ticker: RNAC).
tipranks
Metin Kurtoglu

Metin Kurtoglu
Cartesian Therapeutics (RNAC)
CTO

Ranked #47,375 out of 100,202 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

+1.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$971K
100.00%
A breakdown of Metin Kurtoglu's holdings

Insider Roles

Cartesian Therapeutics
(RNAC)
CTO
Roles that Metin Kurtoglu holds in companies

Most Profitable Insider Trade

Stock:
Cartesian Therapeutics
(RNAC)
Rating:Informative Sell
Date:Dec 11, 2024 - Today
Return:+20.00%
The most profitable trade made by Metin Kurtoglu

Metin Kurtoglu's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cartesian Therapeutics
Dec 11, 2024
CTO
Uninformative Buy
19.27K
$970.65K
Success Rate for
RNAC
1 out of 3 profitable transactions on
RNAC
33%
Average Return for
RNAC
Average return per transaction on
RNAC
+1.07%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 04, 2024
Uninformative Buy
$0.00
-
$0.00
Nov 18, 2024
Uninformative Buy
$116.14K
-
$1.40
Nov 21, 2024
Uninformative Buy
$54.55K
-
$1.40
Dec 11, 2024
Uninformative Buy
$19.27K
-
$1.41
Nov 18, 2024
Informative Sell
$1.44M
-
$17.45
-2.40%
List of latest transactions for each holding click on a transaction to see Metin Kurtoglu's performance on stock

Metin Kurtoglu insider profile FAQ

What is the percentage of profitable transactions made by Metin Kurtoglu?
The percentage of profitable transactions made by Metin Kurtoglu is 33%.
    What is the average return per transaction made by Metin Kurtoglu?
    The average return per transaction made by Metin Kurtoglu is 1.00%.
      What stocks does Metin Kurtoglu hold?
      Metin Kurtoglu holds: RNAC stocks.
        What was Metin Kurtoglu’s latest transaction?
        Metin Kurtoglu latest transaction was an Uninformative Buy of $19.27K.
          What was Metin Kurtoglu's most profitable transaction?
          Metin Kurtoglu’s most profitable transaction was an Informative Sell of RNAC stock on December 11, 2024. The return on the trade was 20.00%.
            What is Metin Kurtoglu's role in Cartesian Therapeutics?
            Metin Kurtoglu's role in Cartesian Therapeutics is CTO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.